Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone

Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone

US Patent 6790858 · Granted Sep 14, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminoquinolones as dgkalpha inhibitors for immune activation2025
Acyl sulfonamides for treating cancer2025
Substituted aminoquinolones as DGKalpha inhibitors for immune activation2024
Substituted aminothiazoles as DGKzeta inhibitors for immune activation2024
2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of can2023
2-phenylpyrimidine-4-carboxamides as AHR inhibitors2022
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists2022
4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides2021
4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides2021
Furane derivatives as inhibitors of ATAD22020
[8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)metha2019
Aryl-cyanoguanidine compounds2018